» Authors » Yoshimitsu Osawa

Yoshimitsu Osawa

Explore the profile of Yoshimitsu Osawa including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 10
Citations 71
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Tabei Y, Ohtsu Y, Shimada M, Wada A, Hamajima E, Osawa Y, et al.
Clin Case Rep . 2024 Jan; 12(1):e8420. PMID: 38223518
Key Clinical Message: This case report describes the clinical course of a juvenile female with FGF23-related hypophosphatemic rickets preceding the onset of SLE. Our study demonstrates the possibility of hypophosphatemic...
2.
Yamada K, Osawa Y, Kobayashi H, Bo R, Mushimoto Y, Hasegawa Y, et al.
Mol Genet Metab Rep . 2022 Nov; 33:100940. PMID: 36406819
Multiple acyl-CoA dehydrogenase deficiency (MADD) is an inherited metabolic disease caused by a defect in electron transfer flavoprotein alpha (ETFA), ETF beta (ETFB), or ETF dehydrogenase (ETFDH), and riboflavin metabolism...
3.
Hattori T, Notsu Y, Tanaka M, Matsui M, Iida T, Watanabe J, et al.
Children (Basel) . 2022 May; 9(5). PMID: 35626871
Flow injection analysis−tandem mass spectrometry (FIA-TMS) has been applied in a first-tier test of newborn screening (NBS). Although isovalerylcarnitine (i-C5), which is a diagnostic indicator of isovaleric acidemia (IVA), is...
4.
Osawa Y, Kobayashi H, Tajima G, Hara K, Yamada K, Fukuda S, et al.
Mol Genet Metab . 2022 Apr; 136(1):74-79. PMID: 35400565
Very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency has been a target of expanded newborn screening (ENBS) using tandem mass spectrometry in Japan. Since the implementation of ENBS, a number of novel...
5.
Osawa Y, Wada A, Ohtsu Y, Yamada K, Takizawa T
Mol Genet Metab Rep . 2020 May; 24:100605. PMID: 32435591
Hyperammonemia is a typical symptom of urea cycle disorders. While early-onset argininosuccinic aciduria (ASA) can often be detected by hyperammonemia, patients with late-onset ASA predominantly present with psychomotor retardation and...
6.
Yamada K, Osawa Y, Kobayashi H, Hasegawa Y, Fukuda S, Yamaguchi S, et al.
Mol Genet Metab Rep . 2019 Dec; 21:100535. PMID: 31844625
Introduction: Various markers, such as C14:1 and the C14:1/C2 ratio, are used as diagnostic markers of very long-chain acyl-CoA dehydrogenase deficiency (VLCADD). However, the levels of these markers in patients...
7.
Kobayashi K, Imagama S, Sato K, Kato F, Kanemura T, Yoshihara H, et al.
Global Spine J . 2018 Dec; 8(8):887-891. PMID: 30560042
Study Design: A review of a prospective database. Objectives: Surgery for elderly patients is increasing yearly due to aging of society and the desire for higher quality of life. The...
8.
Matsumoto T, Imagama S, Inoue H, Aoki T, Ishiguro N, Osawa Y
Asian Spine J . 2015 Dec; 9(6):928-34. PMID: 26713127
Study Design: Prospective comparative study. Purpose: To compare the incidence and severity of adverse reactions associated with myelography performed in outpatients vs. in inpatients and report the safety and usefulness...
9.
Imagama S, Matsuyama Y, Sakai Y, Ito Z, Wakao N, Deguchi M, et al.
Spine (Phila Pa 1976) . 2011 Jan; 36(15):1204-10. PMID: 21217453
Study Design: Prospective, multicenter study. Objective: To conduct peripheral arterial disease (PAD) screening on intermittent claudication (IC) in patients with lumbar spinal canal stenosis (LSCS) to examine the relationships among...
10.
Ito Z, Osawa Y, Matsuyama Y, Aoki T, Harada A, Ishiguro N
J Neurosurg Spine . 2006 Jun; 4(6):509-13. PMID: 16776365
Hypertrophic spinal pachymeningitis (HSP) is a comparatively rare disease characterized by hypertrophic inflammation of the dura mater and clinical symptoms that progress from local pain to myelopathy. The authors report...